Chronic Granulomatous Disease clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
open to all eligible people
This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.
San Francisco, California and other locations
Our lead scientists for Chronic Granulomatous Disease research studies include Morna Dorsey, MD.
Last updated: